Interleukin-6 as a potential indicator for prevention of high-risk adenoma recurrence by dietary flavonols in the polyp prevention trial.
about
New concepts and challenges in the clinical translation of cancer preventive therapies: the role of pharmacodynamic biomarkersDietary Flavonoids, CYP1A1 Genetic Variants, and the Risk of Colorectal Cancer in a Korean population.Astragalin-induced cell death is caspase-dependent and enhances the susceptibility of lung cancer cells to tumor necrosis factor by inhibiting the NF-кB pathway.Serum cytokine concentrations, flavonol intake and colorectal adenoma recurrence in the Polyp Prevention Trial.Do interleukin polymorphisms play a role in the prevention of colorectal adenoma recurrence by dietary flavonols?Role of life events in the presence of colon polyps among African Americans.Lack of significant association between serum inflammatory cytokine profiles and the presence of colorectal adenomaDietary lignan and proanthocyanidin consumption and colorectal adenoma recurrence in the Polyp Prevention Trial.Kaempferol Inhibits Pancreatic Cancer Cell Growth and Migration through the Blockade of EGFR-Related Pathway In Vitro.Plasma soluble receptor for advanced glycation end-products and risk of colorectal adenoma.A review of the dietary flavonoid, kaempferol on human health and cancer chemopreventionEffect of flavonoids on circulating levels of TNF-α and IL-6 in humans: a systematic review and meta-analysis.Dietary Inflammatory Index and Risk of Colorectal Adenoma Recurrence: A Pooled Analysis.Pomegranate for Prevention and Treatment of Cancer: An Update.The efficacy of blueberry and grape seed extract combination on triple therapy for Helicobacter pylori eradication: a randomised controlled trial.The role of dietary polyphenols in the moderation of the inflammatory response in early stage colorectal cancer.Targeted metabolic profiling of pomegranate polyphenols and urolithins in plasma, urine and colon tissues from colorectal cancer patients
P2860
Q26774577-82A47AAF-83AB-4FDC-B1DE-BEF7D55E2283Q33669343-70116E60-DF8C-4346-9F6A-9309B907147FQ33688881-8886953B-1DF7-4B7B-8677-1DD670D63DEBQ34344133-6CD344CD-E2D3-4144-B270-B1071B27E29CQ34532791-C4100C7E-D578-4A7D-B75A-44397E8FF3FDQ34768145-8BB02EC7-9B47-4BBA-8196-3E739640EBC2Q35177880-7C31AC3F-DB86-4848-994C-31BA1E81511AQ35605926-6352064D-8335-40EA-A6A7-B1EAD6C83DC5Q36016793-6C8A391C-61C9-4721-B770-A7EB00CDEF27Q36429573-A09F49F3-E6EB-4C0D-B9DB-8D3F1BE99756Q36696276-DD07D65C-AC5C-434F-8577-D485B9C98A42Q38087565-9B2D40F0-B9ED-46B8-B7DE-009AAF1CE4EEQ38769639-0AF82B5A-5AC7-4B08-8A2D-62CEAD0FFCEDQ39104522-33DF184F-9F42-4834-BC9C-1140A71F298BQ40789345-4037DEBE-5391-455B-BC3D-7E165B319D96Q53217972-3ACEA11C-6A37-4B12-8025-70ED394CF92DQ57759687-2B68B7AE-87A4-465D-84C9-3ED1871EFF47
P2860
Interleukin-6 as a potential indicator for prevention of high-risk adenoma recurrence by dietary flavonols in the polyp prevention trial.
description
2010 nî lūn-bûn
@nan
2010 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Interleukin-6 as a potential i ...... in the polyp prevention trial.
@ast
Interleukin-6 as a potential i ...... in the polyp prevention trial.
@en
type
label
Interleukin-6 as a potential i ...... in the polyp prevention trial.
@ast
Interleukin-6 as a potential i ...... in the polyp prevention trial.
@en
prefLabel
Interleukin-6 as a potential i ...... in the polyp prevention trial.
@ast
Interleukin-6 as a potential i ...... in the polyp prevention trial.
@en
P2093
P2860
P1476
Interleukin-6 as a potential i ...... in the polyp prevention trial.
@en
P2093
Amanda J Cross
Elaine Lanza
Leah B Sansbury
Nancy H Colburn
Paul S Albert
P2860
P304
P356
10.1158/1940-6207.CAPR-09-0161
P577
2010-05-18T00:00:00Z